
Wayne Lewis
Managing Editor at Colorado Outdoorsmag
Love the outdoors, camping, walking and wildlife. Food and drink investing
Articles
-
1 month ago |
phys.org | Xian Xia |Wayne Lewis
Millions of people worldwide are affected by African sleeping sickness, Chagas disease and other life-threatening infections caused by microscopic parasites borne by insects such as the tsetse fly.
-
1 month ago |
newsroom.ucla.edu | Wayne Lewis
Key takeaways: Pancreatic cancer that spreads to the liver is especially difficult to treat because the liver naturally suppresses immune responses, creating an environment where cancer can evade detection and thrive. UCLA researchers have developed a nanoparticle that carries a combination treatment with an mRNA vaccine and a small immune-boosting molecule to the liver, reprogramming it to attack pancreatic cancer.
-
Jan 23, 2025 |
newsroom.ucla.edu | Wayne Lewis
Key takeaways UCLA has one of the first Krios G4 cryo-electron microscopes at a university in the U.S. The Krios G4, which reveals atomic details smaller than the wavelength of visible light, renders them in three dimensions, offering researchers the only way to capture dynamic structures of viral proteins in action.
-
Oct 28, 2024 |
phys.org | Wayne Lewis
Derek Urwin has a special stake in his work as a cancer control researcher. After undergraduate studies in applied mathematics at UCLA, he became a firefighter. His inspiration to launch a second career as a scientist was the loss of his brother, Isaac, who died of leukemia at only 33 despite no history of cancer in their family. Working with Anastassia Alexandrova, a professor of chemistry and biochemistry at UCLA College, he earned his doctorate.
-
Oct 7, 2024 |
uclahealth.org | Wayne Lewis
Imagine a world where your own immune cells are transformed into cancer-fighting superheroes. This is the promise of CAR-T cell therapy, a groundbreaking treatment that’s already saving lives. In this therapy, patients’ own immune cells are collected, genetically engineered so that they specifically target cancer cells, then returned to the body. The result is a potent new option for battling blood cancers.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 136
- Tweets
- 2K
- DMs Open
- No

RT @KodalMinerals: RNS Alert 🚨 Today we released a project update on Bougouni, which has produced over 11k tonnes of spodumene concentrate…

RT @Share_Talk: @KodalMinerals An initial shipment of spodumene concentrate to #China is expected later this quarter. #KOD “Upon completion…

RT @KodalMinerals: CEO, Bernard Aylward, and Operations Director, Steve Zaninovich, holding the first spodumene concentrate product from ou…